rs2075291
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1
The NM_001371904.1(APOA5):c.553G>T(p.Gly185Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00292 in 1,612,572 control chromosomes in the GnomAD database, including 142 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G185D) has been classified as Uncertain significance.
Frequency
Consequence
NM_001371904.1 missense
Scores
Clinical Significance
Conservation
Publications
- hypertriglyceridemia 1Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
- hyperlipoproteinemia type VInheritance: AD, SD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| APOA5 | NM_001371904.1 | c.553G>T | p.Gly185Cys | missense_variant | Exon 3 of 3 | ENST00000227665.9 | NP_001358833.1 | |
| APOA5 | NM_001166598.2 | c.553G>T | p.Gly185Cys | missense_variant | Exon 4 of 4 | NP_001160070.1 | ||
| APOA5 | NM_052968.5 | c.553G>T | p.Gly185Cys | missense_variant | Exon 4 of 4 | NP_443200.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| APOA5 | ENST00000227665.9 | c.553G>T | p.Gly185Cys | missense_variant | Exon 3 of 3 | 1 | NM_001371904.1 | ENSP00000227665.4 | ||
| APOA5 | ENST00000433069.2 | c.553G>T | p.Gly185Cys | missense_variant | Exon 4 of 4 | 1 | ENSP00000399701.2 | |||
| APOA5 | ENST00000673688.1 | c.637G>T | p.Gly213Cys | missense_variant | Exon 3 of 3 | ENSP00000501141.1 | ||||
| APOA5 | ENST00000542499.5 | c.553G>T | p.Gly185Cys | missense_variant | Exon 4 of 4 | 5 | ENSP00000445002.1 |
Frequencies
GnomAD3 genomes AF: 0.00342 AC: 521AN: 152192Hom.: 13 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.00637 AC: 1578AN: 247782 AF XY: 0.00627 show subpopulations
GnomAD4 exome AF: 0.00286 AC: 4182AN: 1460262Hom.: 129 Cov.: 34 AF XY: 0.00314 AC XY: 2284AN XY: 726492 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00341 AC: 520AN: 152310Hom.: 13 Cov.: 34 AF XY: 0.00431 AC XY: 321AN XY: 74472 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hypertriglyceridemia 1 Uncertain:1Other:1
- -
- -
not provided Benign:2
- -
This variant is associated with the following publications: (PMID: 27813673, 31901151, 31619059, 30132804, 30420299, 29263402, 28548292, 27516387, 26079787, 26690388, 25843152, 12915450, 21423763, 20134407, 25487149, 22008704, 25127531, 18635818) -
not specified Benign:1
Variant summary: APOA5 c.553G>T (p.Gly185Cys) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0064 in 248436 control chromosomes, predominantly at a frequency of 0.067 within the East Asian subpopulation in the gnomAD database, including 54 homozygotes. The observed variant frequency within East Asian control individuals in the gnomAD database is approximately 1005 fold of the estimated maximal expected allele frequency for a pathogenic variant in APOA5 causing Hypertriglyceridemia phenotype (6.7e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of East Asian origin. The following publications have been ascertained in the context of this evaluation (PMID: 18635818, 25127531, 20657596). ClinVar contains an entry for this variant (Variation ID: 4402). Based on the evidence outlined above, the variant was classified as likely benign. -
Cardiovascular phenotype Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at